Several years ago, Prof. Eyal Mishani, director of HMO’s Research Fund and the head of the Research and Development and Innovation Division started the work to bring organoid technology developed in the Netherlands in 2009 to Hadassah. He believed that Hadassah could take its potential to the next level. And…